CNBC’s Jim Cramer sits down with Johnson & Johnson CEO Joaquin Duato to talk about the company’s outlook, President Trump’s 100% tariff on some pharmaceutical imports, cancer treatment innovation and more.
Monday, January 5
By webmaster
CNBC’s Jim Cramer sits down with Johnson & Johnson CEO Joaquin Duato to talk about the company’s outlook, President Trump’s 100% tariff on some pharmaceutical imports, cancer treatment innovation and more.
